US Broker Ratings

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: Unpacking a Potential 493.85% Upside

For investors seeking exposure to the biotechnology sector, Cartesian Therapeutics, Inc. (RNAC) presents a compelling prospect. With a market capitalization of $158.79 million, this clinical-stage biotech company is focused on..

AMTD Digital Inc. (HKD) Stock Analysis: Unpacking the 340.9% Revenue Growth in a Niche Market

For investors eyeing opportunities in the technology sector, AMTD Digital Inc. (HKD) presents an intriguing case. With a market capitalization of $556.27 million and a focus on digital solutions, media,..

Marti Technologies, Inc. (MRT) Stock Analysis: A 110% Potential Upside in Turkey’s Tech Transport Revolution

Marti Technologies, Inc. (MRT), a dynamic player in the technology sector, is making significant waves in Turkey’s urban transportation landscape. With a current market capitalization of $189.29 million, this software..

Immutep Limited (IMMP) Stock Analysis: Exploring Growth Potential in Biotech with Robust Revenue Growth

Immutep Limited (NASDAQ: IMMP), an Australia-based biotechnology firm, is making waves in the healthcare sector with its pioneering immunotherapy solutions. Specializing in the development of Lymphocyte Activation Gene-3 related immunotherapies..

Gossamer Bio, Inc. (GOSS) Stock Analysis: Potential 717% Upside in the Biotech Arena

In the realm of biotechnology, Gossamer Bio, Inc. (NASDAQ: GOSS) emerges as a compelling investment opportunity for risk-tolerant investors seeking high-reward scenarios. Based in San Diego, this clinical-stage biopharmaceutical company..

Benitec Biopharma Inc. (BNTC) Stock Analysis: 77.7% Potential Upside Ignites Investor Interest

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is capturing the attention of investors with its innovative approach to genetic medicines. The company, headquartered in Hayward, California, is at..

Compass Therapeutics, Inc. (CMPX) Investor Outlook: Unveiling a 133% Potential Upside in Biotech

For investors looking to capture substantial gains in the healthcare sector, Compass Therapeutics, Inc. (NASDAQ: CMPX) presents a compelling opportunity. With a remarkable potential upside of 133.21%, this Boston-based clinical-stage..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Navigating a 170% Potential Upside with Innovative Biotechnology

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a pioneering company in the biotechnology sector, is attracting attention from investors seeking high-risk, high-reward opportunities. Specializing in the development of mRNA-based therapeutics for..

ZoomInfo Technologies Inc. (GTM) Stock Analysis: Unpacking a 49.76% Potential Upside

ZoomInfo Technologies Inc. (NASDAQ: GTM), a leading provider of go-to-market intelligence and engagement platforms, presents an intriguing opportunity for investors amid a challenging market environment. With its robust suite of..

Neuronetics, Inc. (STIM) Stock Analysis: Unpacking a 211.75% Potential Upside

For investors seeking opportunities in the healthcare sector, Neuronetics, Inc. (NASDAQ: STIM) presents a compelling case, especially given its significant potential upside. The medical device company, headquartered in Malvern, Pennsylvania,..

Yalla Group Limited (YALA) Stock Analysis: Evaluating a 31.5% Potential Upside in the MENA Social Gaming Sector

Yalla Group Limited (NYSE: YALA), a prominent name in the social networking and gaming sector in the Middle East and North Africa (MENA) region, presents a unique investment opportunity with..

Candel Therapeutics, Inc. (CADL) Stock Analysis: Exploring a 266.50% Potential Upside in the Biotech Sector

Candel Therapeutics, Inc. (NASDAQ: CADL) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, specifically within biotechnology. As a clinical-stage biopharmaceutical company, Candel is focused on developing..

Sanara MedTech Inc. (SMTI) Stock Analysis: Unpacking a 79.91% Potential Upside

Sanara MedTech Inc. (NASDAQ: SMTI) stands at the intersection of innovation and opportunity within the healthcare sector, specifically focusing on medical instruments and supplies. With its roots firmly planted in..

Viant Technology Inc. (DSP) Stock Analysis: Exploring a 50.6% Potential Upside for Investors

Viant Technology Inc. (NASDAQ: DSP) is carving out a prominent position in the Technology sector, specifically within the Software – Application industry, with a market capitalization of $736.09 million. Headquartered..

SoundHound AI, Inc. (SOUN) Stock Analysis: Exploring a Potential 86% Upside with Cutting-Edge Voice AI Solutions

SoundHound AI, Inc. (NASDAQ: SOUN), a leading player in the rapidly evolving voice artificial intelligence sector, offers investors a unique opportunity to tap into the burgeoning demand for conversational AI..

Alumis Inc. (ALMS) Stock Analysis: Biotechnology Breakthrough with 58.94% Upside Potential

Alumis Inc. (ALMS), a pioneering biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating autoimmune disorders. Headquartered in South San Francisco, California, this clinical-stage..

Nerdy Inc. (NRDY) Stock Analysis: Exploring a Potential 112% Upside in the Online Learning Space

As the digital landscape continues to evolve, the education sector is increasingly embracing technology to enhance learning experiences. Nerdy Inc. (NRDY), a trailblazer in online education, is strategically positioned within..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Unveiling a 27.93% Potential Upside for Investors

In the ever-evolving realm of healthcare, Cytek Biosciences, Inc. (NASDAQ: CTKB) stands out as a promising player within the medical devices industry. With a market capitalization of $602.9 million, this..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Unlocking 140% Upside Potential in the Biotech Sector

For investors with an eye on emerging biotech opportunities, Tvardi Therapeutics, Inc. (NASDAQ: TVRD) presents a compelling case. With an intriguing 140.15% potential upside based on current analyst targets, this..

Varex Imaging Corporation (VREX) Investor Outlook: Analyzing a 56% Potential Upside for the Medical Device Maker

Varex Imaging Corporation (NASDAQ: VREX), a prominent player in the healthcare sector, has piqued the interest of investors with its promising outlook and substantial potential upside. Despite navigating a challenging..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds